Education
Timely Topics in Transplantation Webinar Series
April 11, 2023
After participating in this webinar, the attendee will be able to:
- Use an intersectionality framework to address access to care for gender diverse patients
- Review pharmacologic considerations for gender-affirming hormone therapy and immunosuppression in transgender and gender diverse (TGD) adult solid organ transplant recipients
- Discuss preventative care and resources available to patients and teams caring for a transgender and gender diverse transplant recipient
Speakers:
- Jennifer Trofe-Clark, PharmD, BCPS, FCCP, FAST • Program Manager, Kidney-Pancreas Transplant Clinical Research Program, Penn Transplant Institute, Philadelphia, PA
- Shelby Smout, PhD • Post-doctoral Research Associate, Psychology, University of Richmond, Richmond, VA
Moderators:
- Lisa Coscia, RN, BSN, CCTC, FAST • Pregnancy Registry Research Coordinator, Transplant Pregnancy Registry International, Philadelphia, PA
- William Asch, MD, PhD, FAST • Associate Professor of Medicine (Nephrology), Yale University, New Haven, CT
Discussant:
- Camilla Nonterah, PhD • Associate Professor of Health Psychology, University of Richmond, Richmond, VA
Additional Resources:
- More on UNOS/OPTN Data Input (via Matthew Cafarella, MPH, Senior Policy Analyst at UNOS): You can read more about the updated MELD score here: https://optn.transplant.hrsa.gov/policies-bylaws/public-comment/improvin.... MELD 3.0 is slated to be implemented later this summer. We are also in the process of developing robust educational resources on the topic prior to implementation. I will also add, related to MELD 3.0, that we are still in the process of refining the planned data collection related to TGD candidates. We will provide more information on that once it is final.
- More on a Presenter's Single-center Experience (via Dr. Jennifer Trofe-Clark): "Ramadan OI, Naji A, Levine MH, Porrett PM, Dunn TB, Nazarian SM, Weinrieb RM, Kaminski M, Johnson D, Trofe-Clark J, Lorincz IS, Blumberg EA, Weikert BC, Bleicher M, Abt PL. Kidney transplantation and donation in the transgender population: A single-institution case series. Am J Transplant. 2020 Oct;20(10):2899-2904. doi: 10.1111/ajt.15963. Epub 2020 May 27. PMID: 32353210" and "Ramadan OI, Naji A, Levine MH, Porrett PM, Dunn TB, Weinrieb RM, Kaminski M, Trofe-Clark J, Lorincz IS, Blumberg E, Weikert BC, Bleicher M, Abt PL. Response to letters concerning: "Kidney transplantation and donation in the transgender population: A single-institution case series". Am J Transplant. 2020 Dec;20(12):3695-3696. doi: 10.1111/ajt.16166. Epub 2020 Jul 22. PMID: 32594653."
This topic was suggested by multiple COPs for consideration as part of the T3 webinar series. The AST Education Committee would like to thank APP COP, IDCOP, PCOP, PSECOP, TxPharm COP, and WHCOP for their suggestions and support. Learn more about AST's COPs at www.myast.org/cops.
January 25, 2023
Speakers:
- Erika Lease, MD • Medical Director, Lung Transplant Program, University of Washington, Seattle, WA
- Allison Kwong, MD • Hepatologist, Stanford University, Stanford, CA
Moderator:
- Pratima Sharma, MD, MBBS, MS • Associate Professor, University of Michigan, Ann Arbor, MI
Discussants:
- Deborah Levine, MD, FAST • Clinical Professor, Medicine, Stanford University, Stanford, CA
- Michael Kriss, MD, FAST • Associate Professor of Medicine, University of Colorado School of Medicine, Aurora, CO
The AST Education Committee would like to thank the Liver & Intestinal Community of Practice (LICOP) and the Thoracic & Critical Care Community of Practice (TCC COP) for suggesting this topic as part of the 2022-2023 T3 webinar series. A related T3 webinar on "Continuous Allocation – Kidney and Pancreas" (suggested by KPCOP and TxAQM COP) was held earlier in the series. Learn more about AST's COPs at www.myast.org/cops.
December 15, 2022
After participating in this webinar, the attendee will be able to:
- Describe the epidemiology of donor derived infections (consider 10-year DTAC review and other DTAC studies).
- Outline the factors to consider during the evaluation of a deceased donor with suspected or proven infection.
- Understand changes to PHS risk definitions and recommendations.
- Describe the emerging novel deceased donor populations (SARS-CoV-2 NAT+, HBsAg+ & HBV DNA+, and Monkeypox).
Speakers:
- Cameron Wolfe, MD, MBBS(Hons), MPH, FIDSA, FAST • Associate Professor of Medicine, Infectious Disease, Duke University Medical Center, Durham, NC
- Marian Michaels, MD, MPH, FAST • Professor of Pediatrics and Surgery, Division of Pediatric Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA
Moderator:
- Ricardo La Hoz, MD, FACP, FIDSA, FAST • Associate Professor of Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX
The AST Education Committee would like to thank the Infectious Disease Community of Practice (IDCOP) for suggesting this topic as part of the 2022-2023 T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.
November 22, 2022
After participating in this webinar, the attendee will be able to:
- Understand the elements of the continuous distribution framework as it is being applied to kidney and KP/PA allocation.
- Understand the progress to date, including policy options that have been evaluated and key themes received during 3 preliminary rounds of public comment.
- Discuss the timeline and key decision points that lie ahead in the efforts toward developing a specific policy proposal.
Speaker:
- Darren Stewart, MS • Associate Director of Registry Studies, Center for Surgical & Transplant Applied Research (C-STAR), NYU Grossman School of Medicine, New York, NY
Moderators:
- Martha Pavlakis, MD FAST, FASN • Medical Director of Kidney and Pancreas Transplantation, Beth Israel Deaconess Medical Center, Boston, MA
- Prince Mohan Anand, MD, FAST, FACP • Medical Director of Kidney Transplant, Medical University of South Carolina, Lancaster, SC
Additional slides and content for this webinar contributed by:
- Hannah Byford, RN, BSN, MPA • Manager - Transplant Quality & Compliance, Froedtert Memorial Lutheran Hospital, Milwaukee, WI
The AST Education Committee would like to thank the Kidney Pancreas Community of Practice (KPCOP) and Transplant Administration and Quality Management Community of Practice (TxAQM COP) for suggesting this topic as part of the 2022-2023 T3 webinar series. A related T3 webinar on "Continuous Allocation – Lung and Liver" (suggested by LICOP and TCC COP) will be held later on in the series. Learn more about AST's COPs at www.myast.org/cops.
November 02, 2022
After participating in this webinar, the attendee will be able to:
- Understand the significance of the moment, including the experience of testifying before Congress, questions asked, and concerns revealed.
- Identify the target population for the new benefit, strategies to identify eligible patients, and how to enroll patients.
- Understand logistics of the coverage, requirements of the prescription, and how the coverage works.
A 1-page, summary handout on Lifelong Immunosuppressive Drug Coverage for Kidney Transplant is available with the on-demand recording.
Speakers:
- Matthew Cooper, MD, FAST • Director, Kidney and Pancreas Transplantation, MedStar Georgetown Transplant Institute, Washington, DC
- Nancy Edgington, LCSW III, CCTSW • Lead Kidney Transplant Social Worker, Yale New Haven Hospital, New Haven, CT
- Jennifer McDermott, PharmD, BCTXP, BCPS • Clinical Pharmacy Specialist, Solid Organ Transplant, Spectrum Health, Grand Rapids, MI
Moderator:
- Lisa Potter, PharmD, BCTXP, FCCP, FAST • Clinical Coordinator, Organ Transplant, University of Chicago Medicine, Chicago, IL
This topic was suggested by the AST Education Committee for inclusion in the 2022-2023 T3 webinar series. The Committee would like to thank the leadership of AST's Transplant Pharmacy Community of Practice (TxPharm COP) for their feedback on session speakers. Learn more about AST's COPs at www.myast.org/cops.
May 18, 2022
After participating in this webinar, the attendee will be able to:
- Identify the most common agents targeted for cost-containment strategies in transplantation.
- Understand the literature support for these cost-containment strategies.
- Describe the applicability of cost-containment strategies in varying patient specific scenarios.
Speakers:
- Margaret R. Jorgenson, PharmD, BCTXP • Clinical Pharmacist, University of Wisconsin Hospital and Clinics, Madison, WI
- Mary Moss Chandran, PharmD, BCTXP, BCPS, CPP, FAST • Clinical Pharmacist Practitioner, Solid Organ Transplant, UNC Hospitals and Clinics, Chapel Hill, NC
Moderator:
- Rita R. Alloway, PharmD, FCCP • Research Professor of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH
AST would like to thank the Transplant Pharmacy Community of Practice (TxPharm COP) for recommending this topic to include as part of the T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.
April 20, 2022
After participating in this webinar, the attendee will be able to:
- Understand our process of eIND approval, background data.
- Understand the postoperative course, xenograft function.
- Understand what we learned from our experience.
Speaker:
- Bartley Griffith, MD, FACS, FRCS • The Thomas E. and Alice Marie Hales Distinguished Professor in Transplantation, University of Maryland School of Medicine, Baltimore, MD
Moderator:
- Jayme Locke, MD, MPH, FACS, FAST • Professor of Surgery, Chief, Division of Transplantation, Arnold G. Diethelm Endowed Chair in Transplantation Surgery, University of Alabama at Birmingham, Birmingham, AL
This topic was suggested by the AST Education Committee for inclusion in the 2021-2022 T3 webinar series. With this session, we hope to provide transplant professionals with the most up-to-date information on the latest developments in Xenotransplantation. AST would like to thank our expert panelists for agreeing to participate in this webinar and sharing their knowledge on the topic.
February 23, 2022
After participating in this webinar, the attendee will be able to:
- Understand incorporation of sex as a biological variable into human clinical research.
- Identify mechanisms mediating how hormones and sex chromosome complement differentially affect immune responses and outcomes of infection and vaccination.
- Describe what clinical differences have been identified in transplant-related infection and vaccination.
- Explain limitations and gaps in knowledge to be addressed in future research.
Speakers:
- Sabra Klein, PhD • Professor, Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
- Whitney Perry, MD, MS • Assistant Professor of Medicine, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA
Moderator:
- Deepali Kumar, MD, MSc, FRCP(C), FAST • Professor of Medicine, Ajmera Transplant Centre, University Health Network, Toronto, ON
AST would like to thank the Community of Transplant Scientists (COTS) and Women's Health Community of Practice (WHCOP) for recommending this topic to include as part of the T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.
January 25, 2022
After participating in this webinar, the attendee will be able to:
- Understand factors and methods to identify an acceptable donor.
- Understand impact of using or not using, acceptable donors on post-transplant outcomes.
- Understand practical methods of matching acceptable donors to appropriate lung transplant recipients.
Speakers:
- Matthew Hartwig, MD, MHS • Associate Professor of Surgery, Duke University Health System, Durham, NC
- Sameep Sehgal, MD, FCCP • Staff Physician, Respiratory Institute, Cleveland Clinic, Cleveland, OH
Moderators:
- Deborah Levine, MD • Professor of Medicine, University of Texas Health Science Center, San Antonio, TX
- Norihisa Shigemura, MD, PhD • Professor of Surgery, Temple University Health System and Lewis Katz School of Medicine, Philadelphia, PA
AST would like to thank the Thoracic and Critical Care Community of Practice (TCC COP) for recommending this topic to include as part of the T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.
December 08, 2021
After participating in this webinar, the attendee will be able to:
- Review racial inequities in access to pre-emptive waitlisting and kidney transplantation that are enabled by flawed features of the US allocation system.
- Review results of survey on opinions of transplant clinicians on use of race in estimating GFR (conducted by AST's Kidney Pancreas Community of Practice Public Policy Work Group).
- Review final recommendations from the American Society of Nephrology (ASN) & National Kidney Foundation (NKF) Task Force to understand: a) Relevance in today’s practice, and b) Trials and tribulations
Speakers:
- Peter Reese, MD, MSCE, FAST • Professor of Medicine and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
- Mona Doshi, MBBS • Clinical Professor, University of Michigan, Ann Arbor, MI
Moderator:
- Silas Norman, MD • Clinical Associate Professor, University of Michigan, Ann Arbor, MI
Discussants:
- Matthew Cooper MD • Director, Kidney and Pancreas Transplantation, MedStar Georgetown Transplant Institute, Washington, DC
- Benjamin Hippen, MD, FAST • Senior Vice President, Head of Transplant Medicine, Fresenius Medical Care, Charlotte, NC
AST would like to thank the Transplant Diagnostics Community of Practice (TxDx COP) and Kidney Pancreas Community of Practice (KPCOP) for recommending this topic to include as part of the T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.